Abstract:Aging of the brain can manifest itself as a memory and cognitive decline, which has been shown to frequently coincide with changes in the structural plasticity of dendritic spines. Decreased number and maturity of spines in aged animals and humans, together with changes in synaptic transmission, may reflect aberrant neuronal plasticity directly associated with impaired brain functions. In extreme, a neurodegenerative disease, which completely devastates the basic functions of the brain, may develop. While cellular senescence in peripheral tissues has recently been linked to aging and a number of aging-related disorders, its involvement in brain aging is just beginning to be explored. However, accumulated evidence suggests that cell senescence may play a role in the aging of the brain, as it has been documented in other organs. Senescent cells stop dividing and shift their activity to strengthen the secretory function, which leads to the acquisition of the so called senescence-associated secretory phenotype (SASP). Senescent cells have also other characteristics, such as altered morphology and proteostasis, decreased propensity to undergo apoptosis, autophagy impairment, accumulation of lipid droplets, increased activity of senescence-associated-β-galactosidase (SA-β-gal), and epigenetic alterations, including DNA methylation, chromatin remodeling, and histone post-translational modifications that, in consequence, result in altered gene expression. Proliferation-competent glial cells can undergo senescence both in vitro and in vivo , and they likely participate in neuroinflammation, which is characteristic for the aging brain. However, apart from proliferation-competent glial cells, the brain consists of post-mitotic neurons. Interestingly, it has emerged recently, that non-proliferating neuronal cells present in the brain or cultivated in vitro can also have some hallmarks, including SASP, typical for senescent cells that ceased to divide. It has been documented that so called senolytics, which by definition, eliminate senescent cells, can improve cognitive ability in mice models. In this review, we ask questions about the role of senescent brain cells in brain plasticity and cognitive functions impairments and how senolytics can improve them. We will discuss whether neuronal plasticity, defined as morphological and functional changes at the level of neurons and dendritic spines, can be the hallmark of neuronal senescence susceptible to the effects of senolytics.

Senescent cell transplantation into the skin induces age-related peripheral dysfunction and cognitive decline

Cell Autonomous and Non-Autonomous Effects of Senescent Cells in the Skin

The aging skin microenvironment dictates stem cell behavior

Senescent human melanocytes drive skin ageing via paracrine telomere dysfunction

Mapping epidermal and dermal cellular senescence in human skin aging

Cell Senescence-Independent Changes of Human Skin Fibroblasts with Age

Organotypic human skin culture models constructed with senescent fibroblasts show hallmarks of skin aging

The bystander effect contributes to the accumulation of senescent cells in vivo

The impact of cellular senescence in skin ageing: A notion of mosaic and therapeutic strategies

Senolytics improve physical function and increase lifespan in old age

Senescent Cell-Secreted Netrin-1 Modulates Aging-Related Disorders by Recruiting Sympathetic Fibers

Impaired immune surveillance accelerates accumulation of senescent cells and aging

Cellular Senescence in Human Skin Aging: Leveraging Senotherapeutics

Skin senescence—from basic research to clinical practice

Blocking negative effects of senescence in human skin fibroblasts with a plant extract

Targeting Senescent Cells for a Healthier Longevity: the Roadmap for an Era of Global Aging

Senescent fibroblasts can drive melanoma initiation and progression

Senescent Cells: Emerging Targets for Human Aging and Age-Related Diseases

Cellular Senescence in Brain Aging

Exosomal miR-767 from senescent endothelial-derived accelerating skin fibroblasts aging via inhibiting TAB1

Transfer learning in a biomaterial fibrosis model identifies in vivo senescence heterogeneity and contributions to vascularization and matrix production across species and diverse pathologies